SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto market shows signs of a rebound, with community members eyeing previous levels from July and anticipating a continued bullish trend. Some are attributing the increase to institutions acquiring positions, while others believe a government shutdown may be a catalyst. Discussions include potential price targets and the possibility of a new all-time high soon.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses its potential in the Real World Asset (RWA) space and anticipates revenue generation. Chatter includes speculation about partnerships, potential buybacks, and the impact of broader market trends on PYTH. Some users are expressing excitement for "PUMPTOBER" and the potential for PYTH to reach new price levels.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid discussions about content choices and potential subscriber impact following calls for a boycott. Community sentiment appears divided, with some citing concerns about specific shows, while others defend the platform's content diversity. The broader context involves debates around cultural representation and its effects on business.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investors anticipate upcoming delivery numbers and debate the impact of expiring EV tax credits, with some expecting a surge in sales while others foresee a drop. Community discussions revolve around the stock's valuation, potential for further gains, and Elon Musk's influence, while some express concerns over declining sales and profit margins.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DKNG is trending due to concerns over increased competition from prediction markets like Kalshi, which are gaining traction and impacting traditional sports betting platforms; the community is debating the long-term effects and potential responses from DraftKings. Some investors express frustration with the company's management and question its ability to innovate and compete effectively, while others view the sell-off as an overreaction and a buying opportunity.

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG) is trending as the community rallies around the joke meta and the classic "What's UpDog?" gag, aiming to bring some levity to the Solana meme coin space. Active community engagement, a long-term project, and its listing on the Jupiter Strict List $JUP are also key points of discussion.

Aventus Network

Aventus Network ($AVT) is trending as community members discuss its low market cap, real-world partnerships, and potential Polkadot integration. Bullish sentiment is building, with traders closely monitoring volume for a breakout, while some suggest a potential link to Donald Trump. The community also highlights Aventus' technology and tokenomics, anticipating a possible altseason rally.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community speculates on potential ETF approval and discusses its impact on the cryptocurrency. Some traders are pointing to technical indicators suggesting a breakout, while others believe it is a pump and dump. There is also ongoing debate about LTC's potential to outperform other cryptocurrencies.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as the community discusses its potential amid increased interest in privacy-focused cryptocurrencies. Some are pointing to the upcoming halving and ZEC's limited supply, drawing comparisons to Bitcoin and anticipating a significant price increase. Recent integrations and developments focused on shielded transactions are also fueling the conversation.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

XLM (Stellar Lumens) is trending due to recent integrations with Visa's stablecoin settlement system and inclusion in the Hashdex Nasdaq Crypto Index ETF, driving community discussion around potential price targets. Technical analysis suggests a confirmed double bottom and bullish divergence, further fueling optimism. Some traders are also comparing XLM to XRP, anticipating a similar price surge.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

General Motors (GM) on Wednesday said that it delivered 710,347 vehicles in the U.S. in the third quarter (Q3), marking a growth of 7.7% year-over-year.Electric vehicle <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.gm.com/static-files/501fc28d-057f-413a-a4cc-0a8a7eaa8257">sales</a> in the quarter hit a fresh record of 66,501 units, marking a growth of 107%, as customers rushed to make their EV purchase before the expiry of the federal tax credit of $7,500 on September 30. The Chevrolet Equinox EV was the company’s best-selling EV in the quarter with 25,085 units delivered. Luxury segment EVs from GM’s Cadillac brand, including the Lyriq, Optiq, and Vistiq, also recorded significant delivery numbers despite higher price points.Chevrolet was the company’s best-selling brand in the quarter, with deliveries rising 8.3% to 710,347 units in the three months through the end of September. While the company’s Cadillac and GMC brands also recorded delivery growth in the quarter, Buick deliveries dropped a steep 14%. GMC is on pace for its best year ever, the company noted. Cadillac, meanwhile, recorded its best third quarter since 2013.Certain models across brands, such as the GMC Terrain, Chevrolet Equinox, Chevrolet Traverse, and Buick Envista, had their best-ever third-quarter sales, the company added. The firm also noted that its fleet business, called GM Evolve, reported a 20% increase in sales in the third quarter.<a href="https://stocktwits.com/symbol/GM">GM shares</a> rose 1% at the time of writing. On Stocktwits, retail sentiment around GM stock fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.GM stock is up by 15% this year and by 37% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/stellantis-expands-partnership-with-mistral-ai-amid-tough-ai-push/chCYBIDR3aU">Stellantis Expands Partnership With Mistral AI Amid Tough AI Push</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of General Motors is seen on a smartphone screen with a steering wheel in the background. (Photo Illustration by Serene Lee/SOPA Images/LightRocket via Getty Images)

General Motors Reports 7.7% Growth In Q3 Auto Sales In US

Electric vehicle sales in the quarter hit a fresh record of 66,501 units as customers rushed to make their EV purchase before the expiry of the federal tax credit of $7,500 on September 30.

Equity

Electric vehicle sales in the quarter hit a fresh record of 66,501 units as customers rushed to make their EV purchase before the expiry of the federal tax credit of $7,500 on September 30.



Jefferies upgraded Carvana (CVNA) to ‘Buy’ from ‘Hold’ on Wednesday, sending shares of the company rallying over 1% in the pre-market session despite weakness in the broader market stemming from the uncertainty around the U.S. government shutdown.The analyst also hiked the price target on the stock to $475, up from $385.. The new price target represents an upside of about 26% from the stock’s last closing price on Tuesday.The firm says the results of its consumer survey, web scape, and capacity analysis suggest Carvana will continue to deliver elevated growth and upside to consensus estimates. In addition, the company's fixed cost leverage will help supplement its revenue growth, supporting further expansion in unit economics and "peer-high" Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) growth, the analyst told investors in a research note, as per TheFly.Jefferies further believes Carvana is best positioned to benefit from a "nascent shift to digital in the massive $800B used car market."On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CVNA">CVNA stock</a> fell to ‘extremely bearish’ from ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:573/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_at_7_42_49_AM_png_78437c581b.webp" alt="CVNA's Sentiment Meter and Message Volume as of 7:43 a.m. ET on Oct. 01, 2025 | Source: Stocktwits" width="573" height="62"><figcaption>CVNA's Sentiment Meter and Message Volume as of 7:43 a.m. ET on Oct. 01, 2025 | Source: Stocktwits</figcaption></figure>On Tuesday, Carvana had announced the launch of same-day delivery in the greater San Francisco Bay Area on the heels of Seattle, the Greater Chicago Area, and other regions, in a bid to raise its appeal to customers in the used car market. With Carvana, customers can find a car, get financing, trade in, and complete a purchase entirely online.In the second quarter (Q2) through the end of June, Carvana sold 143,280 retail units, marking a growth of 41% year-over-year, for a total revenue of $4.84 billion, an all-time quarterly record. The company said in July that it expects a sequential increase in retail units sold in the third quarter (Q3) as well.According to data from Koyfin, 14 of the 22 analysts covering CVNA rate it ‘Buy’ or higher, while seven rate it ‘Hold’ and one ‘Sell.’ The average price target on the stock is $421.95, representing an upside of nearly 12% from the last closing price.CVNA stock is up by 86% this year and has more than doubled its value over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-hikes-model-y-model-3-lease-prices-in-us-after-ev-tax-credit-expiry/chCY2ZTR3aW">Tesla Hikes Model Y And Model 3 Lease Prices In US After EV Tax Credit Expiry</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Carvana logo is seen displayed on a smartphone screen.

Carvana Stock Rallies Pre-Market After Jefferies’s Upgrade, Price Target Hike

Jefferies’s new price target represents an upside of about 26% from the stock’s last closing price on Tuesday. 

Amgen (AMGN) on Friday announced a $650 million expansion of its U.S. manufacturing network, on the heels of President Trump’s latest pharmaceutical tariff announcement.Trump said in a post on Truth Social on Thursday that the United States will impose a 100% tariff on branded and patented pharmaceutical products starting October 1 unless manufacturers are actively building plants in the country.Amgen <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.amgen.com/newsroom/press-releases/2025/09/amgen-announces-650m-expansion-of-us-manufacturing-creating-hundreds-of-new-jobs">said</a> on Friday that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico. The investment is also expected to create about 750 jobs, including construction roles and skilled manufacturing jobs. According to Amgen, the company has invested more than $40 billion in U.S. manufacturing and research and development since late 2017.Earlier this year, the company announced a $900 million expansion of its Ohio manufacturing facility, which followed a late-2024 announcement of a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AMGN">AMGN stock</a> fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:622/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_26_at_1_54_57_PM_png_99b99c433b.webp" alt="AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits" width="622" height="62"><figcaption>AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits</figcaption></figure>Jefferies analyst Akash Tewari stated on Friday that Trump’s tariffs may not have a material impact on pharmaceutical companies, as several large-cap pharmaceutical firms have already announced plans to establish U.S. manufacturing facilities.A Stocktwits user echoed the analyst’s sentiment, stating that Amgen will also likely be unaffected by the tariffs.<stembedurl>https://stocktwits.com/BobBijawklah/message/630132763</stembedurl>AMGN stock is up 4% this year and down by about 15% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bioaffinity-technologies-stock-surge-over-cypath-lung-case-studies/chDVjeMR3ea">bioAffinity Technologies Stock Surged A Whopping 79% Today – Here’s An Important Update</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company logo and the lettering of the biotechnology company Amgen can be seen on the facade of the company's headquarters in Munich (Bavaria) on January 14, 2025. Photo: Matthias Balk/dpa (Photo by Matthias Balk/picture alliance via Getty Images)

Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement

Amgen said that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico.

Bristol Myers Squibb (BMY) announced on Tuesday that a late-stage study evaluating Iberdomide in patients with relapsed or refractory multiple myeloma demonstrated a statistically significant improvement in minimal residual disease (MRD) negativity rates compared to the control arm, when combined with standard therapies.Minimal residual disease (MRD) refers to the small number of cancer cells that may remain in a patient’s body after treatment. MRD assessment has emerged as a highly sensitive and clinically meaningful tool for evaluating treatment response in multiple myeloma, a cancer of plasma cells in the bone marrow that leads to tumors in multiple bones, the company said.While MRD negativity does not necessarily mean all cancer cells are gone, it may predict improved clinical outcomes, including longer remission and survival, it added.The trial will now continue without changes to evaluate the progression-free survival (PFS), overall survival, and safety endpoints, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://news.bms.com/news/corporate-financial/2025/Bristol-Myers-Squibb-Announces-Phase-3-EXCALIBER-RRMM-Study-Evaluating-Iberdomide-in-Combination-with-Standard-Therapies-Demonstrated-a-Significant-Improvement-in-Minimal-Residual-Disease-Negativity-Rates-in-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx">said</a>. Bristol Myers noted that it plans to discuss the results with health authorities.Shares of BMY traded marginally higher at the time of writing. On Stocktwits, retail sentiment surrounding <a href="https://stocktwits.com/symbol/BMY">BMY stock</a> remained within the ‘bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:581/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_23_at_12_52_19_PM_png_34f256a597.webp" alt="BMY's Sentiment Meter and Message Volume as of 12:05 p.m. ET on Sept. 23, 2025 | Source: Stocktwits" width="581" height="60"><figcaption>BMY's Sentiment Meter and Message Volume as of 12:05 p.m. ET on Sept. 23, 2025 | Source: Stocktwits</figcaption></figure>Earlier this month, BioNTech SE (BNTX) and Bristol Myers Squibb also presented interim data from a global randomized mid-stage trial evaluating their drug Pumitamig plus chemotherapy in patients with extensive-stage small cell lung cancer. The data showed encouraging anti-tumor responses, with a positive trend in progression-free survival, or the length of time a patient with a disease lives without it worsening.According to Koyfin data, 19 out of 26 analysts covering Bristol-Myers stock rate it a ‘Hold’, six rate it ‘Buy’ or higher, while one rates it a ‘Sell.’ The average price target on the stock is $52, representing an upside of over 17% from current price levels.BMY stock is down by about 20% this year and by about 10% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/moderna-says-updated-mnexspike-covid-shot-demonstrated-rbust-immune-response-in-study/chDhMlcR35J">Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Bristol-Myers Squibb Company logo is seen displayed on a tablet. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

Bristol Myers Announces Positive Outcomes From Multiple Myeloma Late-Stage Study

The company announced that the trial will proceed without changes to evaluate the progression-free survival, overall survival, and safety endpoints.

Shares of Kenvue slumped 6% on Monday afternoon following reports that the Trump administration is expected to unveil efforts exploring how Tylenol's active ingredient may be linked to autism.The Wall Street Journal <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.washingtonpost.com/health/2025/09/21/trump-autism-announcement-tylenol-leucovorin/">reported</a> on Monday, citing four people familiar with the matter, that federal health officials are expected to raise concerns about pregnant women using acetaminophen, the active ingredient in Tylenol. They plan to warn pregnant women against using Tylenol early or unless they have a fever, sources told WSJ.Officials also intend to tout a drug called Leucovorin as a potential autism treatment, the report said. Leucovorin is a prescription medication typically used in cancer treatment to counter the harmful side effects of other drugs.White House press secretary Karoline Leavitt, however, urged people to await an announcement today from President Trump at a press briefing.“...before you jump to conclusions based on reports that the White House has not even confirmed, I would encourage everyone in this room to go into the four o'clock announcement with some critical thinking skills and with some open ears to actually listen to what the President and his team of outsiders have to say about this. And there will be a number of things that will be announced and discussed,” she said.Tylenol is made by McNeil Consumer Healthcare, a division of Kenvue, though other companies also sell acetaminophen-based products. It is widely used as a pain reliever, including by pregnant women.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/KVUE">KVUE stock</a> jumped from ‘bearish’ to ‘bullish’ over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:574/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_22_at_2_12_39_PM_png_4b40cf5a25.webp" alt="KVUE's Sentiment Meter and Message Volume as of 2:12 p.m. ET on Sept. 22, 2025 | Source: Stocktwits" width="574" height="61"><figcaption>KVUE's Sentiment Meter and Message Volume as of 2:12 p.m. ET on Sept. 22, 2025 | Source: Stocktwits</figcaption></figure>Trump, speaking at a memorial for conservative activist Charlie Kirk on Sunday, also touted a big announcement pertaining to autism. “Tomorrow we’re going to have one of the biggest announcement[s] … medically, I think, in the history of our country,” he said, as reported by WSJ. “I think you’re going to find it to be amazing. I think we found an answer to autism.”Earlier this month, it was reported that Kenvue Inc. reportedly <a href="https://stocktwits.com/news-articles/markets/equity/tylenol-kenvue-met-rfk-jr-to-keep-off-autism-list/chw8MshRdDV">met</a> with the U.S. Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of treatments causing autism.“We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers,” Kenvue <a href="https://stocktwits.com/news-articles/markets/equity/kenvue-jnj-retail-traders-cautious-as-health-officials-plan-to-announce-tylenol-links-to-autism/chDQOxLR3cI">told</a> WSJ in a statement. Autism spectrum disorder (ASD) is a complex developmental condition involving persistent challenges with social communication, restricted interests, and repetitive behavior.KVUE stock is down by 20% this year and by about 25% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lyft-awarded-with-yet-another-price-target-hike-after-waymo-partnership/chDQu3aR32s">Lyft Awarded With Yet Another Price Target Hike After Waymo Partnership</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Kenvue logo is seen displayed on a smartphone screen. U.S. health officials will hold a press conference on autism, which is expected to link Kenvue's Tylenol to the disease. (Illustration by Thomas Fuller/Getty Images)

Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease

The Wall Street Journal reported on Monday, citing four people familiar with the matter, that federal health officials are expected to raise concerns about pregnant women using acetaminophen, the active ingredient in Tylenol.

Darden CFO Raj Vennam said the significant step down in traffic during July, led to the firm’s first quarter earnings being lower than expected

Darden Restaurants Sees Slew Of Price Target Cuts As Rising Costs Cloud Profit Outlook

Wells Fargo lowered the firm's price target on Darden to $200 from $225, noting that Darden’s comparable sales were good, but the weak flow-through is a pinch point due to rising beef costs and value investments.

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted two positive opinions for Merck’s (MRK) blockbuster cancer drug Keytruda, the company said on Friday.While one of the opinions recommends approval for a new subcutaneous route of administration and a new solution form for injection for Keytruda, the other recommends approval for the drug in treating locally advanced head and neck squamous cell carcinoma, Merck <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.merck.com/news/merck-receives-two-positive-eu-chmp-opinions-for-keytruda-pembrolizumab-for-subcutaneous-sc-administration-and-for-new-indication-for-earlier-stage-head-and-neck-cancer/">said</a>.The committee’s recommendations will now be reviewed by the European Commission. Final decisions on marketing authorization in the European Union, Iceland, Liechtenstein, and Norway are expected in the fourth quarter.Shares of the company rose marginally in Friday’s pre-market session. On Stocktwits, retail sentiment about <a href="https://stocktwits.com/symbol/MRK">MRK stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume fell from ‘normal’ to ‘low’ levels.If approved for under-the-skin administration by a healthcare provider, the solution form for injection of Keytruda will be marketed in the European Union as Keytruda SC, the company said. It could be administered in one minute every three weeks or in two minutes every six weeks, offering an alternative to intravenous infusion.“If approved, we believe KEYTRUDA SC has the potential to provide meaningful benefits to patients and providers in Europe because it can offer a shorter administration time compared to KEYTRUDA and the option to receive treatment in additional health care settings,” said Marjorie Green, senior vice president and head of oncology at Merck Research Laboratories. CHMP’s positive opinion applies to all Keytruda indications approved for adult patients in Europe.An application seeking approval of subcutaneous Keytruda is currently under review in the U.S. as well. The U.S. Food and Drug Administration is expected to decide on the application by September 23.The second CHMP opinion recommends approval of Keytruda as treatment of resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Head and neck cancer describes several different tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. It is estimated that there were more than 947,200 new cases of head and neck cancer diagnosed globally and more than 482,400 deaths from the disease in 2022, Merck said.Keytruda is Merck’s best-selling drug. In the second quarter, the company reported sales of $8 billion from Keytruda, representing a 9% year-over-year growth.MRK stock is down 18% this year and approximately 30% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-edge-lower-ahead-of-trump-xi-call/chD3b7SR3Rq">Dow Futures Edge Lower As Investors Watch Out For Trump-Xi Call: FDX, UPS, LEN, INTC Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck Says EMA Committee Adopted Two Positive Opinions For Expanding Use Of Cancer Drug Keytruda

While one of the opinions recommends approval for a new subcutaneous route of administration for Keytruda, the other recommends approval for the drug in treating locally advanced head and neck squamous cell carcinoma, according to Merck. 

Meta Platforms (META) Chief Product Officer Chris Cox reportedly said that smart glasses will be the future of computing devices.According to a CNBC report on Thursday, Cox said in an interview, “We talk to them, we will see with them, we will use gestures the same way we interact with each other to interact with our computers.”“The interfaces will get more natural, and so we certainly believe that the next really important wearable technology is going to be a pair of glasses,” Cox told CNBC.Retail sentiment about the stock improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with chatter at ‘high’ levels, according to data from Stocktwits. Shares of the company were up nearly 1% during midday trading.On Wednesday, Mark Zuckerberg unveiled the Meta Ray-Ban Display AI glasses at the Meta Connect 2025 conference. Zuckerberg noted that these were the advanced AI glasses to date, featuring a full-color, high-resolution display. The company said that each pair comes with its own Meta Neural Band, an EMG wristband that translates the signals created by human muscles, such as subtle finger movements, into commands for the glasses.Meta said that the price of the glasses starts at $799, which includes both the glasses and the Meta Neural Band. Meta Ray-Ban Display will hit shelves September 30 at limited brick-and-mortar retailers in the U.S., the company said. These retailers would be Best Buy, Sunglass Hut, and Ray-Ban Stores.Cox, on Thursday, told CNBC that users will be able to record videos and also send messages via voice or physically using handwriting gestures on their knee.Shares of <a href="https://stocktwits.com/symbol/META">Meta</a> have gained nearly 34% this year and increased by 40% over the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/darden-flags-q2-profit-slowdown-amid-surging-beef-costs/chD2bM4R3b1">Darden Flags Q2 Profit Slowdown Amid Surging Beef Costs, CFO Says Price Spike Is Unsustainable</a>

The Meta Ray-Ban smart glasses are exhibited in Matte Black and Dusty Blue colors during the Mobile World Congress 2025 in Barcelona, Spain, on March 5, 2025. 

Meta’s Chief Product Officer Has An Interesting Take On Smart Glasses – More Details Inside

In an interview with CNBC, Cox stated that humans communicate with them, they see with them, and use gestures in the same way they interact with each other to interact with computers.

Darden Restaurants’ (DRI) Chief Financial Officer, Raj Vennam, stated that the company has reaffirmed its full-year earnings per share (EPS) forecast and anticipates the lowest year-over-year EPS growth to occur in the second quarter, driven by a significant increase in beef costs and a measured approach to pricing these costs.“There's been a significant spike in beef costs recently, especially tenders and rib eyes. We don't believe these price levels are sustainable,” Vennam said on a post-earnings call.He added that due to the significant price increase, the company was starting to see “some demand destruction in retail.” “I guess really the big picture, beef is the biggest variable here. The other component here where you're seeing a higher inflation is on seafood, primarily due to the tariffs on shrimp,” stated Vennam.Darden maintained its fiscal 2026 adjusted EPS forecast to be between $10.50 and $10.70. The company now expects annual sales growth to be between 7.5% and 8.5%, compared with the previous forecast of 7% to 8% increase.Retail sentiment on <a href="https://stocktwits.com/symbol/DRI">Darden</a> remained unchanged in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels, according to data from Stocktwits. Shares of the company were down 10% in early trading.<figure class="image"><img style="aspect-ratio:792/97;" src="https://news.stocktwits-cdn.com/DRI_sentiment_png_ac1a6e526e.webp" alt="DRI sentiment.png" width="792" height="97"><figcaption>DRI sentiment and message volume September 18, 2025, as of 11 am ET | Source: Stocktwits</figcaption></figure>The company reported that total sales at Olive Garden increased by 7.6%, driven by strong same-restaurant sales and traffic growth. LongHorn traffic was up about 3.2% for the quarter, and same restaurant sales for the segment rose 5.5%, Darden said.Darden’s first-quarter sales came in at $3.04 billion, in line with analysts’ expectations. Its adjusted EPS was $1.97, compared with estimates of $2.01.Shares of Darden have gained nearly 2% this year and increased by 10% over the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ftc-sues-ticketmaster-live-nation-over-illegal-ticket-resale-tactics-report/chD2GVlR3bK">FTC Sues Ticketmaster, Live Nation Over ‘Illegal’ Ticket Resale Tactics: Report</a>

The exterior of a LongHorn Steakhouse restaurant is seen on December 19, 2024 in Austin, Texas. 

Darden Flags Q2 Profit Slowdown Amid Surging Beef Costs, CFO Says Price Spike Is Unsustainable

The company now expects annual sales growth to be between 7.5% and 8.5%, compared with the previous forecast of 7% to 8% increase.

The U.S. Federal Trade Commission (FTC) reportedly sued Ticketmaster and Live Nation Entertainment (LYV) regarding tactics related to “illegal” ticket resale.According to a CNBC report, a lawsuit was filed in California’s federal court, and seven states joined the complaint, including Florida, Illinois, and Virginia.The report added that the FTC wrote in the filing that these companies “tacitly worked” with scalpers, which allowed them to “unlawfully purchase” tickets and help in boosting their profits.″[Ticketmaster and Live Nation’s] illegal conduct frustrates artists’ desire to maintain affordable ticket prices that fit the needs of ordinary American families, costing ordinary fans millions of dollars every year,”&nbsp;the lawsuit stated, according to CNBC.Retail sentiment on <a href="https://stocktwits.com/symbol/LYV">Live Nation</a> dipped to ‘neutral’ from ‘bullish’ territory a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits. Shares of the company were down nearly 3% during midday trading.The report added that the FTC’s lawsuit alleges Ticketmaster employs a “bait and switch” strategy, which allows it to alter the company’s advertising of ticket prices only to inflate the final cost. It also claims that the company knowingly permits brokers to exceed ticket limits for resale, violating the Better Online Ticket Sales Act.CNBC reported that the FTC alleged Ticketmaster was involved in “triple dipping” by charging fees at multiple stages, collecting fees from brokers in both the primary and secondary markets, as well as from consumers in the secondary market. The report, citing the FTC, said that the company generated $3.7 billion from resold tickets between 2019 and 2024.The report added that according to the FTC, Ticketmaster manages about 80% of major concert venues, and that between 2019 and 2024, consumers spent over $82 billion on tickets through the platform.Shares of Live Nation have gained 27% this year and jumped nearly 58% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/cracker-barrel-in-spotlight-after-slew-of-price-target-cuts/chDczFIR3bg">Cracker Barrel In Spotlight After Slew Of Price Target Cuts: Citi Says Q1 Began In A ‘Deep Traffic Hole’ Post Logo Change</a>

Live Nation CEO says momentum continues to build amid infrastructure expansion.

FTC Sues Ticketmaster, Live Nation Over ‘Illegal’ Ticket Resale Tactics: Report

According to a CNBC report, a lawsuit was filed in California’s federal court, and seven states joined the complaint, including Florida, Illinois, and Virginia.

Dimensional ETF Trust - Dimensional US High Profitability ETF

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

DUHP
Dimensional ETF Trust - Dimensional US High Profitability ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest DUHP News

DUHP Dimensional ETF Trust - Dimensional US High Profitability ETF